COVID-19-free pracoviště: Vyšetření protilátek proti koronaviru jako základ testovací strategie ve firmách

Warning

This publication doesn't include Institute of Computer Science. It includes Faculty of Science. Official publication website can be found on muni.cz.
Title in English COVID-19-free workplace: Measuring the level of antibodies against coronavirus as a basis for testing strategy in companies
Authors

ZUZANA Krátká SEDLÁČKOVÁ Lenka LUXOVÁ Štěpánka HRUBÁ Dana KATINA Stanislav

Year of publication 2021
Type Article in Periodical
Magazine / Source Časopis lékařů českých
MU Faculty or unit

Faculty of Science

Citation
web https://www.prolekare.cz/en/journals/journal-of-czech-physicians/2021-4-5/covid-19-free-workplace-measuring-the-level-of-antibodies-against-coronavirus-as-a-basis-for-testing-strategy-in-companies-127892
Keywords COVID-19; SARS-CoV-2; antibody; seroprevalence study; antigen test;PCR test
Description The Czech Republic is one of the countries most affected by the coronavirus pandemic – approximately 16% of the population had a positive PCR test, 2–3 times more people underwent infection without undergoing this examination. It is particularly useful for employers to know how many employees have already contracted the infection and for how many people are still at risk of the coronavirus infection. For this purpose, it is appropriate to examine IgG antibodies. However, the testing strategy is different at present – antigen testing is mandatory to look for infectious individuals, regardless of human immunity. The aim of the pilot study was to determine the number of immune individuals after infection at three clinics of GENNET s.r.o. At the same time, unvaccinated individuals who had not had COVID-19 or had undergone it more than three months ago were tested with antigen tests. The cohort included 297 subjects, of whom 182 were not vaccinated (61.3 %) and 115 subjects (38.7 %) were after the vaccination. Of the unvaccinated, 71 people had in the past a positive PCR test (39 %), another 18 people had positive IgG antibodies without infection (9.9 %) and 38 people (20.9 %) had negative IgG antibodies. So far, 55 persons (30.2 %) have not been examined. If we add people vaccinated and people with antibodies, then 74.3 % of employees of the GENNET Archa clinic, 68 % of employees from the GENNET Kostelní clinic and 58.1 % from the GENNET Liberec clinic were immune to infection. 153 individuals on average (60 of whom had antibodies) were tested for the antigen test in four rounds. The infection was detected in two people. Both belonged to the group without tested antibodies. No person with antibodies was tested positive for antigen. People who have antibodies after vaccination or infection are substantially less prone to infection and have a low risk of continuing to spread the virus. By examining antibodies, employers will gain a better overview of the situation in the workplace. Based on our study, we recommend including antibody testing into antiepidemic measures and limit antigen testing to seronegative individuals.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.

More info